Search
Beyondspring Inc
BYSIAdd to Watchlist
0.750USD
+0.041+5.78%
Close 09-18 16:00（ET）
29.69MMarket Cap
LossP/E TTM
More Details of Beyondspring Inc Company
BeyondSpring Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to improve clinical outcomes for patients with high unmet medical needs. Its lead asset, Plinabulin, is in late-stage clinical development as an anti-cancer agent in non-small cell lung cancer (NSCLC) and a range of cancer indications. The Company’s mechanism of action as a dendritic cell maturation agent supports both anti-cancer activity and immune modulation, offering an approach to resensitizing tumors to checkpoint inhibitors. It also has a pipeline of immuno-oncology product candidates, BPI-002 program, which is based on an oral small molecule agent that increases T-cell co-stimulation; BPI-003 program, which is based on a small molecule inhibitor of IKK, a protein kinase, and BPI-004 program, which is focused on a small molecule that induces the production of neo-antigens by tumor cells, allowing tumors containing no immune cells to be infiltrated by the immune system.
Beyondspring Inc Profile
Ticker SymbolBYSI
Company nameBeyondspring Inc
IPO dateMar 09, 2017
CEOHuang (Lan)
Number of employees40
Security typeOrdinary Share
Fiscal year-endMar 09
Address100 Campus Drive, West Side, 4Th Floor
CityFLORHAM PARK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07932
Phone16465284184
Websitehttps://www.beyondspringpharma.com/en/
Ticker SymbolBYSI
IPO dateMar 09, 2017
CEOHuang (Lan)
Company Executives of Beyondspring Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Lan Huang, Ph.D.
Dr. Lan Huang, Ph.D.
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
5.29M
+24.38%
Dr. Lan Huang, Ph.D.
Dr. Lan Huang, Ph.D.
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
5.29M
+24.38%
Dr. Jiangwen (Jen) Majeti, Ph.D.
Dr. Jiangwen (Jen) Majeti, Ph.D.
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
50.91K
--
Dr. Jiangwen (Jen) Majeti, Ph.D.
Dr. Jiangwen (Jen) Majeti, Ph.D.
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
50.91K
--
Mr. Patrick (Pat) Fabbio
Mr. Patrick (Pat) Fabbio
Independent Director
Independent Director
24.59K
-119.03%
Mr. Patrick (Pat) Fabbio
Mr. Patrick (Pat) Fabbio
Independent Director
Independent Director
24.59K
-119.03%
Mr. Min Qiu
Mr. Min Qiu
Chief Executive Officer
Chief Executive Officer
2.50K
--
Mr. Min Qiu
Mr. Min Qiu
Chief Executive Officer
Chief Executive Officer
2.50K
--
Mr. Matthew Kirkby
Mr. Matthew Kirkby
Independent Director
Independent Director
--
-100.00%
Mr. Brendan P. Delaney
Mr. Brendan P. Delaney
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Lan Huang, Ph.D.
Dr. Lan Huang, Ph.D.
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
5.29M
+24.38%
Dr. Lan Huang, Ph.D.
Dr. Lan Huang, Ph.D.
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
5.29M
+24.38%
Dr. Jiangwen (Jen) Majeti, Ph.D.
Dr. Jiangwen (Jen) Majeti, Ph.D.
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
50.91K
--
Dr. Jiangwen (Jen) Majeti, Ph.D.
Dr. Jiangwen (Jen) Majeti, Ph.D.
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
50.91K
--
Mr. Patrick (Pat) Fabbio
Mr. Patrick (Pat) Fabbio
Independent Director
Independent Director
24.59K
-119.03%
Mr. Patrick (Pat) Fabbio
Mr. Patrick (Pat) Fabbio
Independent Director
Independent Director
24.59K
-119.03%
FAQs
Who are the top five shareholders of Beyondspring Inc?
The top five shareholders of Beyondspring Inc are: Dr. Lan Huang, Ph.D.
How many institutions hold shares of Beyondspring Inc (BYSI)?
As of 2026Q1, 50 institutions hold shares of Beyondspring Inc, with a combined market value of approximately 6.01M, accounting for 14.61% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -378641.00.